Back to top

Versigent Limited (VGNT) Receives a Buy from Goldman Sachs

Goldman Sachs analyst Mark Delaney initiated coverage with a Buy rating on Versigent Limited today and set a price target of $48.00. According to T...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE: